Inactivating mutations in components of the epigenetic regulator polycomb repressive complex 2 (PRC2), such as EZH2, SUZ12, EED, are frequently detected in ETP-ALL and are associated with aberrant RAS signalling in response to the loss of the H3K27me3 repressive histone mark. Here, EZH2 is linked to acute lymphoblastic leukemia.